GlassScriptPhysician profile
Mark S Davids
NPI 1265477434
$2,791.88
in general payments reported to CMS, 2019-2025
21 companies · $790 in 2025
The $790 reported for 2025 was more than what 75% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $81.62 · 2020: $103 · 2021: $106 · 2022: $380 · 2023: $360 · 2024: $971 · 2025: $790.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,121.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,120.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $586.93 | 2020-2025 | Augment Injectable, Infinity Adaptis, Viaflow |
| Smith+Nephew, INC. | $477.79 | 2020-2025 | Grafix Pl, Stravix Pl, Renasys Go V2 Home |
| Arthrex, INC. | $429.23 | 2024-2025 | |
| Boston Scientific Corporation | $212.81 | 2023-2025 | Varithena Administration Pack, General - Pain Management |
| Paragon 28, INC. | $161.22 | 2022-2024 | Bun-Yo-Matic |
| Grt US Holding, INC. | $153.32 | 2022 | |
| Amgen INC. | $141.91 | 2024-2025 | Krystexxa |
| Horizon Therapeutics Plc | $127.51 | 2019-2022 | |
| Integra Lifesciences Corporation | $108.70 | 2020-2025 | Tcc-Ez, Integra, Integra Dermal Regeneration Template |
| Kerecis Limited | $53.12 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Abbvie INC. | $45.93 | 2025 | |
| Abbott Laboratories | $41.94 | 2025 | Proclaim |
| Next Science LLC | $41.37 | 2024 | Xperience, Surgx, Blastx |
| Wright Medical Technology, INC. | $39.93 | 2020 | |
| Orthofix Medical, INC. | $37.31 | 2021-2023 | Physio-Stim |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $26.76 | 2021 | |
| Globus Medical, INC. | $25.34 | 2025 | Senza |
| Convatec INC. | $24.36 | 2023 | |
| Paratek Pharmaceuticals, INC. | $21.93 | 2021 | |
| Embody, INC. | $20.03 | 2021 | |
| Organogenesis INC. | $14.44 | 2023 | Puraply |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Davids listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.